US Covid Cases Rise Rapidly as Delta Dominates, Vaccination Stabilizes

Covid cases are rising rapidly in the United States as the highly infectious delta variant dominates and vaccination remains stable, data showed on Wednesday.

According to the Centers for Disease Control and Prevention (CDC), the seven-day average of new cases as of July 6 was 13,859, up 21 percent from two weeks ago.

Reporting lag after the 4th of July holiday weekend could lead to more cases involving the most recent days.

According to the CDC, the spike comes as the delta variant, which is more permeable than any previous strain, accounted for about 52 percent of cases in the two weeks ending July 3.

America’s vaccination campaign has dropped sharply since April, despite the highest availability of vaccines in any country.

President Joe Biden missed his goal of at least partially vaccinating 70 percent of adults by Independence Day, the current figure being 67 percent.

Areas with low vaccination rates in the Midwest and South are experiencing higher case rates than regions with high vaccination rates, such as the Northeast, a trend that has become increasingly apparent in recent weeks.

Local media reported that a hospital in Springfield, Missouri, ran short of ventilators to treat hospitalized Covid patients over the weekend.

The Kansas City Star said the city’s two hospitals of 160,000 were treating 213 COVID-19 patients as of Monday, 168 on Friday and 31 on May 24.

The Johns Hopkins Center for Amesh Adalja said, “The trajectory that we are likely to see is two different flavors of the pandemic in the United States, one of which is it’s more of a problem in places where there are high levels of non-vaccination.” person.” Health Protection told AFP.

“In other parts of the country, the pandemic is going to be largely managed as a normal respiratory virus,” he said.

Adalja said he envisioned a “decoupling” of hospitalizations and deaths from rising cases in highly vaccinated areas despite Delta becoming the dominant strain, as seen in Israel.

“Increasingly, I think we need to start turning our attention away from cases and really hospitalization, because the vaccine was designed to do that – it’s going to have to reduce cases from hospitalization. was designed for,” he said.

Real-world data has shown that vaccines from Pfizer, Johnson & Johnson and AstraZeneca retained high efficacy against severe COVID-19 and the same is true of the modern vaccine, according to experts.

read all Breaking Newshandjob today’s fresh news and coronavirus news Here

.

Leave a Reply